The expression of SOX10 and its value for predicting tumor biological behaviors in patients suffering gastric adenocarcinoma, cross sectional study

Abstract

Background Special attention has been recently paid to the expression of the SOX10 marker, which is actually responsible for coordinating the signaling process of the Wnt/B-catenin evolutionary pathway and therefore responsible for cell proliferation and differentiation in tumor cells. We aimed to study the expression of this marker in different types of gastric adenocarcinomas and to find its relationship with histopathologic features of the tumor. Methods This cross-sectional study was performed on patients with gastric adenocarcinoma (diffuse or intestinal type) whose malignancy could be confirmed by tissue. Subjects were classified according to CAP criteria based on pathology results. Patients underwent immunohistochemical staining to evaluate SOX10 expression. Tumor behavior was determined based on histological studies. Results SOX10 positivity was reported in 22.5% of all tissue samples assessed. The assessment of relationship between SOX10 expression and baseline and tumor characteristics showed no significant association of SOX10 expression and patients’ gender, age, tumor location, tumor size, its type and also lymphovascular and perineural invasions. Conclusion The expression of the SOX10 marker is expected only in 22.5% of patients diagnosed with gastric cancer. In our society, the expression of this marker has nothing to do with the biological and aggressive behaviors of this tumor. Highlights

Lymphovascular Invasion Evaluation by the CD31 Expression in Gastric Adenocarcinoma

“…The mechanism of GC development and metastasis has great significance due to varied disease-free survival frequencies in the patients with similar histopathologic findings ( 13 ). There are some helpful prognostic markers for GC ( 14 ). In the GC tissues, the lymphatic and blood vessels density was shown to be higher compared to the normal tissues, immunohistochemically ( 15 ).…”

The Role of P21 Protein Expression in Predicting Progression and Biological Behaviors of Gastric Adenocarcinomas

“…A network of interactions between genes, transcription factors, sig-naling pathways and protein enzymes act in the proliferation, and continuation of the cycle of tumoral cells (7). So, some biomarkers have been described for the diagnosis and outcome prediction of cancers (8). Any alteration of the promoter or suppressor oncogenes encoding regulators of cell cycles contributes to carcinogenesis and invasive behaviors of cancer, such as invasion and metastasis.…”